Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study.

Jyun-Heng LaiMeng-Ting WangChia-Chao WuYa-Ling HuangChieh-Hua LuJun-Ting Liou

Published in: Pharmacoepidemiology and drug safety (2020)

Concurrent use of amiodarone and sulfonylureas is associated with an increased risk of serious hypoglycemia among diabetic patients, with an elevated risk for amiodarone used in a long-term or at a high daily dose.

Keyphrases

type diabetes
physical activity
early onset
wound healing
radiation therapy
metabolic syndrome
adipose tissue
case control
rectal cancer